These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21046289)

  • 1. Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
    Donohue MM; Tirschwell DL
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):52-60. PubMed ID: 21046289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
    George J; Doney A; Palmer CN; Lang CC
    Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
    Ross S; Paré G
    Pharmacogenomics; 2013 Oct; 14(13):1565-72. PubMed ID: 24088127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and cardiovascular disease--implications for personalized medicine.
    Johnson JA; Cavallari LH
    Pharmacol Rev; 2013 Jul; 65(3):987-1009. PubMed ID: 23686351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of Stroke.
    Ross S; Paré G
    Stroke; 2018 Oct; 49(10):2541-2548. PubMed ID: 30355125
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
    Shahin MH; Johnson JA
    Curr Opin Cardiol; 2013 May; 28(3):305-14. PubMed ID: 23478884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of warfarin and aspirin in secondary prevention of stroke.
    Elkind MS
    Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease gets personal.
    Hayden EC
    Nature; 2009 Aug; 460(7258):940-1. PubMed ID: 19693052
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics of neural injury recovery.
    Pearson-Fuhrhop KM; Cramer SC
    Pharmacogenomics; 2013 Oct; 14(13):1635-43. PubMed ID: 24088134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
    Hankey GJ
    Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
    Cavallari LH; Mason DL
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents.
    Yazbeck A; Akika R; Awada Z; Zgheib NK
    Pharmacogenet Genomics; 2024 Apr; 34(3):61-72. PubMed ID: 38372412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
    Furlan AJ
    Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
    Kozdağ G; Yaymacı M; Ertaş G; Celikyurt U; Sahin T; Kılıç T; Ural D
    Heart Vessels; 2012 Nov; 27(6):568-75. PubMed ID: 21909806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of anti-platelet and anti-coagulation therapy.
    Fisch AS; Perry CG; Stephens SH; Horenstein RB; Shuldiner AR
    Curr Cardiol Rep; 2013 Jul; 15(7):381. PubMed ID: 23797323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955
    [No Abstract]   [Full Text] [Related]  

  • 18. Good old warfarin for stroke prevention in atrial fibrillation.
    Verheugt FW
    Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
    [No Abstract]   [Full Text] [Related]  

  • 19. Watching the WATCH trial: the role of sponsors and data monitoring committees.
    Califf RM
    J Card Fail; 2004 Apr; 10(2):113-4. PubMed ID: 15101021
    [No Abstract]   [Full Text] [Related]  

  • 20. Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
    Fabiaña N; Ramaswami AP; Ang ES; De Silva DA
    Ann Acad Med Singap; 2015 Jul; 44(7):266-8. PubMed ID: 26377061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.